Back to top

Psychedelic: Cybin receives European approval for EMBRACE study

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on trial approvals, earnings and ana...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

COMPASS Pathways PLC Sponsored ADR (CMPS)

Cybin Inc. (CYBN)

GH Research PLC (GHRS)

Mind Medicine (MindMed) Inc. (MNMD)

SciSparc Ltd. (SPRC)